4WM
RLAY icon

49 Wealth Management’s Relay Therapeutics RLAY Stock Holding History

49 Wealth Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,029
Closed -$110K – 269
2026
Q1 		$110K Sell
11,029
-372
-3% -$3.33K 0.01% 195
2025
Q4 		$96.5K Sell
11,401
-1,700
-13% -$12.1K 0.01% 192
2025
Q3 		$68.4K Buy
+13,101
New +$50K 0.01% 192

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

49 Wealth Management's RLAY Position: Q2 2026 in Review

49 Wealth Management sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 11,029 shares — an estimated $110K sold.

49 Wealth Management first reported a position in RLAY in Q3 2025 and held it in 3 quarters. The position peaked at $110K in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • 49 Wealth Management reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • 49 Wealth Management sold 11,029 Relay Therapeutics shares in Q2 2026, an estimated $110K.
  • 49 Wealth Management first reported a position in Relay Therapeutics in Q3 2025 and held it in 3 quarters.
  • 49 Wealth Management's Relay Therapeutics position peaked at $110K in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.